Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q2 2026Earnings call Aug 4, 2026 · most recent call
GILD’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: Gilead Sciences’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: GILD daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
No 8-K events recorded since this call day.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
Full Pro access for 30 days when you create a free account. No credit card required.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $7.57B | +6.4% | $1.42 | +24.6% | 79.1% | 32.4% | 23.6% | $2.83B |
| FY2025 Q1 | $6.67B | -0.3% | $1.04 | +131.1% | 76.9% | 33.6% | 19.7% | $1.65B |
| FY2025 Q2 | $7.08B | +1.8% | $1.56 | +20.9% | 78.8% | 34.9% | 27.7% | $720M |
| FY2025 Q3 | $7.77B | +3.0% | $2.43 | +143.0% | 79.8% | 42.8% | 39.3% | $3.96B |
| FY2025 Q4 | $7.92B | +4.7% | $1.74 | +22.5% | 79.5% | 37.7% | 27.5% | $3.12B |
| FY2026 Q1 | $6.96B | +4.4% | $1.61 | +54.8% | 79.2% | 37.2% | 29.0% | $2.43B |
| FY2026 Q2Selected | $7.80B | +10.2% | $-8.43 | -640.4% | — | -133.2% | -134.5% | $3.69B |
Management-stated figures from GILD’s newest call are part of Tellvest Pro.